A unique product development partnership seeks to address the need for new therapeutics for Chagas disease by developing and testing vaccine candidate antigens that would eventually comprise a ...

Chagas disease, caused by the Trypanosoma cruzi parasite and transmitted by insects in Latin America is among the most common tropical diseases, and so far without effective vaccine. A study ...

The advantages of a therapeutic Chagas disease vaccine compared with benznidazole alone (the current major competing product in clinical use) could include the following: Three recent ...

Main Goal: The overall goal of the project is to advance the first therapeutic Chagas disease vaccine prototype through a First-in-Human Phase 1 clinical trial. SARS-CoV Vaccine Development Main Goal: ...

which have been patented and are progressing toward the first-ever clinical trial of Chagas disease vaccine candidates. "Dr. Farani's more sensitive approach to DNA extraction represents a ...

University of Cincinnati biologists are studying the lifecycle of the Chagas disease parasite to develop a cure, aiming to ...

Chagas disease is often called a silent killer because many people don't realize they have it until complications from the ...

Humans can only transmit the disease to other humans during pregnancy and birth or via blood transfusions and organ donations. Currently, there are no medications or vaccines to prevent Chagas ...

There is no vaccine for this disease ... The PCR is better at diagnosing a current, active infection. While Chagas disease is not high on the list of things to worry about in our community ...

Chagas disease isn’t well-known in America ... They can cause serious side effects, especially in older people. There is no vaccine. The best way to prevent it is by avoiding triatomine bugs.